Aldeyra Therapeutics to Present at 2019 Cantor Global Healthcare Conference

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will present at the 2019 Cantor Global Healthcare Conference. The presentation is scheduled to begin at 11:15 a.m. ET on Friday, October 4, 2019. A live webcast of the presenta

Full Story →